Savara Inc - Common Stock, par value $0.001 per share (SVRA)
CUSIP: 805111101
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 210,922,101
- Total 13F shares
- 167,625,869
- Share change
- +2,536,275
- Total reported value
- $382,185,936
- Put/Call ratio
- 0%
- Price per share
- $2.28
- Number of holders
- 121
- Value change
- +$4,604,999
- Number of buys
- 59
- Number of sells
- 62
Quarterly Holders Quick Answers
What is CUSIP 805111101?
CUSIP 805111101 identifies SVRA - Savara Inc - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 805111101:
Top shareholders of SVRA - Savara Inc - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Ali Behbahani |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
24,471,264
|
$108,897,125 | — | 17 Jul 2023 | |
| Anthony A. Florence Jr. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
24,471,264
|
$108,897,125 | — | 17 Jul 2023 | |
| Carmen Chang |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
24,471,264
|
$108,897,125 | — | 17 Jul 2023 | |
| Forest Baskett |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
24,471,264
|
$108,897,125 | — | 17 Jul 2023 | |
| Growth Equity Opportunities 17, LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
24,471,264
|
$108,897,125 | — | 17 Jul 2023 | |
| Mathers Edward T. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
24,471,264
|
$108,897,125 | — | 17 Jul 2023 | |
| Mohamad Makhzoumi |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
24,471,264
|
$108,897,125 | — | 17 Jul 2023 | |
| Paul Edward Walker |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
24,471,264
|
$108,897,125 | — | 17 Jul 2023 | |
| Rick Yang |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
24,471,264
|
$108,897,125 | — | 17 Jul 2023 | |
| Scott D. Sandell |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
24,471,264
|
$108,897,125 | — | 17 Jul 2023 | |
| NEA Management Company, LLC |
13F
|
Company |
12%
|
24,471,264
|
$67,785,401 | — | 31 Mar 2025 | |
| Bain Capital Life Sciences Fund II, L.P. |
13D/G
|
— |
10%
|
17,600,621
|
$55,969,975 | $0 | 25 Mar 2025 | |
| Bain Capital Life Sciences Investors, LLC |
13F
|
Company |
8.3%
|
17,600,621
|
$48,753,720 | — | 31 Mar 2025 | |
| TCG Crossover Management, LLC |
13F
|
Company |
5.9%
|
12,362,205
|
$34,243,308 | — | 31 Mar 2025 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
5.4%
|
11,462,301
|
$31,750,574 | — | 31 Mar 2025 | |
| Vestal Point Capital, LP |
13F
|
Company |
5.2%
|
11,000,000
|
$30,470,000 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
4.7%
|
9,946,311
|
$27,551,282 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.8%
|
8,119,247
|
$22,490,314 | — | 31 Mar 2025 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
3.8%
|
8,075,375
|
$22,368,789 | — | 31 Mar 2025 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
3.8%
|
7,964,000
|
$22,060,280 | — | 31 Mar 2025 | |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
|
Company |
3.2%
|
6,835,000
|
$18,932,950 | — | 31 Mar 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13D/G
13F
|
Company |
3.2%
|
5,481,654
|
$17,431,660 | $0 | 31 Dec 2024 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
2.6%
|
5,481,666
|
$15,184,215 | — | 31 Mar 2025 | |
| VR Adviser, LLC |
13F
|
Company |
1.5%
|
3,257,639
|
$9,023,660 | — | 31 Mar 2025 | |
| EMERALD ADVISERS, LLC |
13F
|
Company |
1.5%
|
3,090,213
|
$8,559,890 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.3%
|
2,822,237
|
$7,819,405 | — | 31 Mar 2025 | |
| Rosalind Advisors, Inc. |
13F
|
Company |
1.3%
|
2,654,944
|
$7,354,195 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
1.2%
|
2,449,651
|
$6,785,533 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
1%
|
2,183,660
|
$6,048,738 | — | 31 Mar 2025 | |
| EMERALD MUTUAL FUND ADVISERS TRUST |
13F
|
Company |
0.96%
|
2,014,456
|
$5,580,043 | — | 31 Mar 2025 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
0.64%
|
1,360,291
|
$3,768,006 | — | 31 Mar 2025 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.61%
|
1,284,151
|
$3,557,098 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.5%
|
1,056,178
|
$2,925,613 | — | 31 Mar 2025 | |
| AXA S.A. |
13F
|
Company |
0.5%
|
1,048,441
|
$2,904,182 | — | 31 Mar 2025 | |
| SUPERSTRING CAPITAL MANAGEMENT LP |
13F
|
Company |
0.46%
|
966,203
|
$2,676,382 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.45%
|
954,830
|
$2,644,879 | — | 31 Mar 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.43%
|
916,017
|
$2,537,367 | — | 31 Mar 2025 | |
| Exome Asset Management LLC |
13F
|
Company |
0.4%
|
836,397
|
$2,316,819 | — | 31 Mar 2025 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.38%
|
797,327
|
$2,208,596 | — | 31 Mar 2025 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.37%
|
778,954
|
$2,157,703 | — | 31 Mar 2025 | |
| Sio Capital Management, LLC |
13F
|
Company |
0.34%
|
719,654
|
$1,993,442 | — | 31 Mar 2025 | |
| READYSTATE ASSET MANAGEMENT LP |
13F
|
Company |
0.25%
|
522,791
|
$1,448,131 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.24%
|
504,011
|
$1,396,110 | — | 31 Mar 2025 | |
| Badrul A. Chowdhury |
3/4/5
|
CHIEF MEDICAL OFFICER |
—
mixed-class rows
|
400,000
mixed-class rows
|
$1,335,000 | — | 14 Dec 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.22%
|
467,547
|
$1,295,105 | — | 31 Mar 2025 | |
| Raymond Dennis Pratt |
3/4/5
|
Chief Medical Officer |
—
mixed-class rows
|
620,050
mixed-class rows
|
$1,124,103 | — | 12 Dec 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.19%
|
405,604
|
$1,123,523 | — | 31 Mar 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.18%
|
385,103
|
$1,066,735 | — | 31 Mar 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.14%
|
288,674
|
$799,627 | — | 31 Mar 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.13%
|
263,715
|
$730,491 | — | 31 Mar 2025 |
Institutional Holders of Savara Inc - Common Stock, par value $0.001 per share (SVRA) as of Q2 2025
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.